SK302004A3 - Heterocyklické zlúčeniny a ich použitie ako inhibítory D-Ala-D-Ala ligázy - Google Patents

Heterocyklické zlúčeniny a ich použitie ako inhibítory D-Ala-D-Ala ligázy Download PDF

Info

Publication number
SK302004A3
SK302004A3 SK30-2004A SK302004A SK302004A3 SK 302004 A3 SK302004 A3 SK 302004A3 SK 302004 A SK302004 A SK 302004A SK 302004 A3 SK302004 A3 SK 302004A3
Authority
SK
Slovakia
Prior art keywords
group
alkyl
aryl
compound
hydrogen
Prior art date
Application number
SK30-2004A
Other languages
English (en)
Slovak (sk)
Inventor
Scott T. Moe
Paul J. Ala
Emanuele Perola
Carlos H. Faerman
Jacob J. Clement
Janid A. Ali
Paul M. Will
Salvatore A. Marchese
Andrew S. Magee
John V. Gazzaniga
Christopher Farady
Manuel A. Navia
Patrick R. Connelly
Original Assignee
Pliva, D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva, D.D. filed Critical Pliva, D.D.
Publication of SK302004A3 publication Critical patent/SK302004A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK30-2004A 2001-06-28 2002-06-28 Heterocyklické zlúčeniny a ich použitie ako inhibítory D-Ala-D-Ala ligázy SK302004A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30168501P 2001-06-28 2001-06-28
PCT/US2002/020567 WO2003001887A2 (en) 2001-06-28 2002-06-28 Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors

Publications (1)

Publication Number Publication Date
SK302004A3 true SK302004A3 (sk) 2005-07-01

Family

ID=23164426

Family Applications (1)

Application Number Title Priority Date Filing Date
SK30-2004A SK302004A3 (sk) 2001-06-28 2002-06-28 Heterocyklické zlúčeniny a ich použitie ako inhibítory D-Ala-D-Ala ligázy

Country Status (16)

Country Link
US (3) US20030176436A1 (pl)
EP (2) EP1411949A4 (pl)
CN (2) CN1543465A (pl)
BG (1) BG108548A (pl)
BR (1) BR0211310A (pl)
CA (2) CA2451840A1 (pl)
CZ (2) CZ200443A3 (pl)
EA (1) EA200400094A1 (pl)
EE (2) EE200400042A (pl)
HU (2) HUP0700040A2 (pl)
IL (2) IL159538A0 (pl)
MX (1) MXPA04000159A (pl)
PL (2) PL374589A1 (pl)
SK (1) SK302004A3 (pl)
WO (2) WO2003002064A2 (pl)
YU (2) YU102503A (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0217703D0 (en) * 2002-07-31 2002-09-11 Univ Liverpool Pharmaceutical composition
KR100915481B1 (ko) * 2004-11-09 2009-09-03 에프. 호프만-라 로슈 아게 아미노퀴나졸린 화합물
WO2007009911A1 (en) * 2005-07-21 2007-01-25 F. Hoffmann-La Roche Ag PYRIDO [2 , 3-D] PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS
GB0608822D0 (en) * 2006-05-04 2006-06-14 Chroma Therapeutics Ltd Inhibitors of DHFR
SI22338A (sl) * 2006-08-18 2008-02-29 Univerza V Ljubljani, Fakulteta Za Farmacijo Diazendikarboksamidi kot inhibitorji d-alanil-d-alanin ligaze
TW200831528A (en) 2006-11-30 2008-08-01 Astrazeneca Ab Compounds
CN101084901B (zh) * 2007-06-22 2011-12-21 复旦大学 一种葡萄球菌抑制剂
WO2009097578A1 (en) 2008-02-01 2009-08-06 Takeda Pharmaceutical Company Limited Oxim derivatives as hsp90 inhibitors
US8426044B2 (en) 2009-03-20 2013-04-23 Board Of Regents, The University Of Texas System Method for imparting antimicrobial activity to a medical device
MX2012002544A (es) * 2009-08-31 2012-04-11 Dow Agrosciences Llc Pteridinas y sus usos como agroquimicos.
SG11201606876RA (en) 2015-03-04 2016-10-28 Gilead Sciences Inc Toll like receptor modulator compounds
CN106316966A (zh) * 2015-06-15 2017-01-11 董运勤 医药中间体n-(2-吡嗪甲基)苄胺磷酸盐化合物制备方法
SI3507276T1 (sl) 2016-09-02 2022-01-31 Gilead Sciences, Inc. Spojine modulatorja toličnih receptorjev
WO2018045150A1 (en) 2016-09-02 2018-03-08 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
JP7630906B2 (ja) 2017-02-01 2025-02-18 イェール・ユニヴァーシティー 利尿薬耐性の治療
SG11202006157VA (en) 2018-01-05 2020-07-29 Corvidia Therapeutics Inc Methods for treating il-6 mediated inflammation without immunosuppression
MA54864A (fr) * 2019-02-01 2021-12-22 Fmc Corp Pyridines et pyrimidines diamino-substituées à titre d'herbicides
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI879779B (zh) 2019-06-28 2025-04-11 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法
GB2626567A (en) * 2023-01-26 2024-07-31 De Montfort Univ Quinazoline derivatives for use as a medicament

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2949466A (en) * 1958-03-04 1960-08-16 Parke Davis & Co Pyrimidine compounds and means of producing the same
US3134778A (en) * 1963-08-20 1964-05-26 Smith Kline French Lab 2,5,7-triamino-4-phenyl (or thienyl)-pyrimido[4,5-d]pyrimidines
RO56210A2 (pl) 1970-12-28 1974-08-01
US4079056A (en) * 1975-03-31 1978-03-14 The United States Of America As Represented By The Department Of Health, Education And Welfare Method of making pteridine compounds
DE2750288A1 (de) * 1977-11-10 1979-05-17 Thomae Gmbh Dr K Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3445298A1 (de) 1984-12-12 1986-06-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue pteridine, verfahren zu ihrer herstellung und deren verwendung als zwischenprodukte oder als arzneimittel
WO1992017478A1 (en) 1991-04-08 1992-10-15 Duquesne University Of The Holy Ghost 5-ALKYL-6-[[AMINO]METHYL]PYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AND METHODS OF PREPARING AND USING THESE DERIVATIVES
US5547954A (en) * 1994-05-26 1996-08-20 Fmc Corporation 2,4-Diamino-5,6-disubstituted-and 5,6,7-trisubstituted-5-deazapteridines as insecticides
ES2207657T3 (es) * 1995-02-27 2004-06-01 F. Hoffmann-La Roche Ag Pirrolderivados de dioxopirrolo.
WO1999050264A1 (en) * 1998-03-30 1999-10-07 Kyowa Hakko Kogyo Co., Ltd. Quinazoline derivatives
JP2000239277A (ja) * 1999-02-19 2000-09-05 Kyowa Hakko Kogyo Co Ltd イミダゾキナゾリン誘導体
GB0219893D0 (en) 2002-08-27 2002-10-02 Melacure Therapeutics Ab Pharmaceutically active compounds

Also Published As

Publication number Publication date
EP1411949A2 (en) 2004-04-28
PL374259A1 (pl) 2005-10-03
YU102503A (sh) 2006-08-17
HUP0700040A2 (en) 2007-05-29
WO2003001887A2 (en) 2003-01-09
EP1432713A2 (en) 2004-06-30
YU102303A (sh) 2006-08-17
US20030181470A1 (en) 2003-09-25
US7345048B2 (en) 2008-03-18
CN1543465A (zh) 2004-11-03
HUP0700061A2 (en) 2007-05-02
CZ200442A3 (cs) 2004-10-13
US20080090847A1 (en) 2008-04-17
CA2451800A1 (en) 2003-01-09
EP1432713A4 (en) 2005-05-11
WO2003002064A3 (en) 2003-10-23
WO2003001887A3 (en) 2003-08-21
CA2451840A1 (en) 2003-01-09
PL374589A1 (pl) 2005-10-31
EE200400043A (et) 2004-10-15
BG108548A (bg) 2005-05-31
IL159538A0 (en) 2004-06-01
BR0211310A (pt) 2006-10-31
US20030176436A1 (en) 2003-09-18
EE200400042A (et) 2004-10-15
CN1547472A (zh) 2004-11-17
EA200400094A1 (ru) 2005-08-25
CZ200443A3 (cs) 2004-08-18
IL159540A0 (en) 2004-06-01
WO2003002064A2 (en) 2003-01-09
EP1411949A4 (en) 2004-11-24
MXPA04000159A (es) 2005-01-07

Similar Documents

Publication Publication Date Title
US20080090847A1 (en) Heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors
US20200140460A1 (en) Antibacterial therapeutics and prophylactics
JP2002505689A (ja) キノリン−インドール抗菌剤、それらに関する用途及び組成物
US20090042927A1 (en) Salts, Prodrugs and Polymorphs of Fab I Inhibitors
JP5897566B2 (ja) 環式n,n’−ジアリールチオ尿素及びn,n’−ジアリール尿素−アンドロゲン受容体アンタゴニスト、抗癌剤、その調製のための方法及び使用
RU2625305C2 (ru) Твердые формы ингибитора гиразы (r)-1-этил-3-[6-фтор-5[2-(1-гидрокси-1-метил-этил) пиримидин-5-ил]-7-(тетрагидрофуран-2-ил)-1н-бензимидазол-2-ил] мочевины
US12522598B2 (en) 3-(2-(heteroaryl)-pyridin-4-yl)-5-(trifluoromethyl)-1,2,4-oxadiazole derivatives as HDAC6 inhibitors
CN101263146A (zh) 抗感染试剂8-甲氧基-9h-异噻唑并[5,4-b]喹啉-3,4-二酮及相关化合物
CA2824401A1 (en) Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea
US20090137681A1 (en) Sirtuin Inhibiting Compounds
CN103130686B (zh) N,n′-不对称二芳基取代脲类化合物及其制备方法和用途
EP3506922A1 (en) Substituted urea depsipeptide analogs as activators of the clpp endopeptidase
US20030120073A1 (en) Alpha-ketocarboxylic acid based inhibitors of phosphoryl tyrosine phosphatases
US20030166645A1 (en) Novel nitrofuran-containing heterocyclic compounds and uses thereof
WO2023114366A2 (en) Sulfonamide derivatives and their use as soluble epoxide hydrolase inhibitors
AU2002324455A1 (en) Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors
Ahmed et al. Synthesis and in vitro antibacterial activity of morpholine derived benzenesulphonamides
KR20060002915A (ko) 결정성 n-포르밀 히드록실아민 화합물
US12503476B2 (en) Ring-fused 2-pyridone compounds, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria
JP2004137185A (ja) チオフェン骨格を有する抗菌剤
US20230095547A1 (en) Method for inhibiting growth of bacteria
US20110230533A1 (en) Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use
JP2017105714A (ja) 多剤排出ポンプ阻害剤
CN118666840A (zh) 螺[吡咯烷-3,3′-喹啉]-2,2′-二酮哌啶甲酰胺类化合物的设计合成与应用
FARHAN Prof. Dr. Kawkab Y. Saour

Legal Events

Date Code Title Description
FC9A Refused patent application